Agenda

Friday, September 25

  • 08:30 AM - 09:30 AM
    Research and Big Data Carl McKinley, Privacy and Compliance Officer, Regenstrief Institute
    • What are your concerns about using AI in healthcare?
    • How is AI already being used in healthcare?
    • What do you want compliance to understand about AI?
    • What is bias in AI and how does bias effect AI?
  • 09:30 AM - 09:45 AM
    Break
  • 09:45 AM - 10:45 AM
    Telehealth: The New Normal Nicholas Merker, Partner, Ice Miller
    • How health care professionals are adapting away from the in-person visit and to telehealth from a business perspective
    • What does telehealth compliance look like and how do professionals prepare for the inevitable withdrawal of OCR’s leniency enforcement period after COVID-19
    • Billing compliance issues in a telehealth world
  • 10:45 AM - 11:00 AM
    Break
  • 11:00 AM - 12:00 PM
    Perspectives of Compliance Officers: How to Thrive as a Compliance Officer Jasmin French, Sr Mgr Ethics & Compliance, Cummins Inc. Steven Guymon, Corporate Ethics and Compliance Officer, Eli Lilly and Company Clarice McCauley, Assistant General Counsel, Ethics & Compliance, Roche Diagnostics Corporation
    • Discover diverse digital communications methods that "stick" among a workforce that is working remotely
    • Understand the elements of a robust policy management system
    • Hear approaches to evaluate your speak-up and non-retaliation cultures amidst the current climate of social injustice.
  • 12:00 PM - 01:00 PM
    Lunch Break
  • 01:00 PM - 02:00 PM
    Pharmacy Compliance Katea Ravega, Quarles & Brady
    • Understanding the status of coronavirus-related pharmacy changes
    • 340B Compliance Update and Hot Topics
    • Pharmacy audit prep
    • Controlled substances compliance
  • 02:00 PM - 02:15 PM
    Break
  • 02:15 PM - 03:15 PM
    OIG Mandated Six-Year Look Back Audits Chad Eckhardt, Partner and Chair - Healthcare Innovation Team, Frost Brown Todd LLC James Rose, Managing Director, SunHawk Consulting LLC
    • Use of Statistical Sampling and Extrapolation
    • Recent Updates and Perspectives
    • Drivers of Efficient and Diligent Analysis
  • 03:15 PM - 03:30 PM
    Break
  • 03:30 PM - 04:30 PM
    Measuring the Effectiveness of a Compliance Program Using the DOJ Guidance Joseph Zielinski, Senior Counsel, Wooden McLaughlin llp
    • How to analyze the three "fundamental questions" that pursuant to Department of Justice guidance should be asked to determine the effectiveness of a compliance program
    • How to apply and reference other compliance guidance to the Department of Justice’s three "fundamental questions"
    • How to assess the effectiveness of a compliance program using the DOJ’s guidance, which specifically calls out various elements associated with a compliance program and what questions to ask to assess these elements (tool provided to assist in this assessment)
Home Home HCCA Official Site
Join our Social Network
Copyright © 2020 Health Care Compliance Association (HCCA). All rights reserved. All information provided through this site, including without limitation all information such as the "look and feel" of the site, data files, graphics, text, photographs, drawings, logos, images, sounds, music, video or audio files on this site, is owned and/or licensed by HCCA or its suppliers and is subject to United States and international copyright, trademark and other intellectual property laws. Any third party logos and/or content provided herein is owned by such third parties and is used by permission herein. Your use of this site to is subject to our Terms of Use and Privacy Statement.